CEACAM5 and teratoma: We found that a combination of two biomarkers, carcinoembryonic antigen (CEA) and human chorionic gonadotropin (HCG), enabled the detection of 87% (7/8) of teratomas once teratomas had reached a volume >40 mm3 (Figure 4A).